A case of autoimmune polyendocrine syndrome type 1

doi:10.11852/zgetbjzz2024-1394

Abstract

CLC Number:

R179

Dilareyi·Dawulietihan, Luo Yanfei, Mayila·Abudureyimu, Mireguli·Maimaiti. A case of autoimmune polyendocrine syndrome type 1[J]. Chinese Journal of Child Health Care, 2025, 33(12): 1397-1400.

迪拉热依·达吾列提汉, 罗燕飞, 玛依拉·阿不都热依木, 米热古丽·买买提. 自身免疫性多发内分泌腺病综合征1型1例[J]. 中国儿童保健杂志, 2025, 33(12): 1397-1400.

[1] Bruserud Ø, Oftedal BE, Landegren N, et al. A longitudinal follow-up of autoimmune polyendocrine syndrome type 1[J]. J Clin Endocrinol Metab, 2016, 101(8):2975-2983.
[2] Kahaly GJ, Frommer L. Autoimmune polyglandular diseases[J]. Best Pract Res Clin Endocrinol Metab, 2019, 33(6):101344.
[3] Fierabracci A. Type 1 diabetes in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome (APECED): A "rare" manifestation in a "rare" disease[J]. Int J Mol Sci, 2016, 17(7):1106.
[4] Wu H, Mo Y, Yu S, et al. Novel homozygous mutations in AIRE leading to APS-1 and potential mechanisms based on bioinformatics analysis[J]. Heliyon, 2024, 10(6):e28037.
[5] 金雨, 杨涛. 自身免疫性多发性内分泌腺病综合征[J]. 内科急危重症杂志, 2015, 21(4):259-262.
Jin Y, Yang T. Autoimmune multiple endocrinopathies syndrome[J]. Journal of Acute and Critical Medicine, 2015, 21(4):259-262.(in Chinese)
[6] Brad GF, Nicoarǎ DM, Scutca AC, et al. Exploring chronic hypocalcemia: Insights into autoimmune polyglandular syndrome type 1—a case study and literature review[J]. J Clin Med, 2024, 13(8):2368.
[7] Cutolo M. Autoimmune polyendocrine syndromes[J]. Autoimmun Rev, 2014, 13(2):85-89.
[8] Philippot Q, Casanova J-L, Puel A. Candidiasis in patients with APS-1: Low IL-17, high IFN-γ, or both?[J]. Curr Opin Immunol, 2021, 72:318-323.
[9] Guo C-J, Leung PSC, Zhang W, et al. The immunobiology and clinical features of type 1 autoimmune polyglandular syndrome (APS-1)[J]. Autoimmun Rev, 2018, 17(1):78-85.
[10] Yukina M, Erofeeva T, Nurana N, et al. Novel gene mutations regulating immune responses in autoimmune polyglandular syndrome with an atypical course[J]. J Endocr Soc, 2021, 5(8):bvab077.
[11] YHH ek E, Simsek T, Cilingir O. Early-onset chronic keratitis as the first presenting component of autoimmune polyendocrinopathy syndrome type 1 (APS-1): A case report and review of the literature[J]. J Clin Res Pediatr Endocrinol, 2023,17(3):359-364.
[12] Stolarski B, Pronicka E, Korniszewski L, et al. Molecular background of polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome in a Polish population: Novel AIRE mutations and an estimate of disease prevalence[J]. Clin Genet, 2006, 70(4):348-354.
[13] Fierabracci A, Lanzillotta M, Vorgučin I, et al. Report of two siblings with APECED in Serbia: Is there a founder effect of c.769C>T AIRE genotype?[J]. Ital J Pediatr, 2021, 47(1):126.
[14] 孙永香,何亚非,栗夏连.1例自身免疫性多内分泌腺病综合征Ⅰ型患者的临床及家系AIRE基因突变分析[J].中国当代儿科杂志,2016,18(2):147-151.
Sun YX, He YF, Li XL. Clinical and familial analysis of AIRE gene mutation in a patient with autoimmune polyendocrine syndrome type Ⅰ[J].Chin J Contemp Pediatr, 2016,18(2):147-151.(in Chinese)
[15] Bjørklund G, Pivin M, Hangan T, et al. Autoimmune polyendocrine syndrome type 1: Clinical manifestations, pathogenetic features, and management approach[J]. Autoimmun Rev, 2022, 21(8):103135.
[16] Radetti G, Puel A, Franceschi R, et al. A non-classical presentation of APECED in a family with heterozygous R203X AIRE gene mutation[J]. J Endocrinol Invest, 2022, 46(3):629-632.
[17] Kisand K, Peterson P. Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy[J]. J Clin Immunol, 2015, 35(5):463-478.
[18] 郑粼琳, 刘毅. 自身免疫多内分泌腺病综合征研究进展[J]. 临床误诊误治, 2019, 32(12):103-108.
Zheng LL, Liu YI. Research progress of autoimmune polyendocrine syndrome[J]. Clinical misdiagnosis and mistreatment, 2019, 32(12):103-108. (in Chinese)
[19] Tenório JR, Tuma MM, Andrade NS, et al. Oral manifestations of autoimmune polyglandular syndrome type 1[J]. Spec Care Dentist, 2022, 42(5):531-535.
[20] Zhan F, Cao L. Late-onset autoimmune polyendocrine syndrome type 1: A case report and literature review[J]. Immunol Res, 2021, 69(2):139-144.
[21] Belllo MO, Garla VV. Polyglandular autoimmune syndrome type Ⅰ[M]. Treasure Island(FL):StatPearls Publishing,2019.
[22] Mezgueldi E, Bertholet-Thomas A, Milazzo S, et al. Early-onset hypoparathyroidism and chronic keratitis revealing APECED[J]. Clin Case Rep, 2015, 3(10):809-813.
[23] 熊燕. 自身免疫性多内分泌腺病综合征一例[J]. 新医学, 2015, 46(4):268-272.
Xiong Y. A case of autoimmune polyendocrine syndrome[J]. New Medicine, 2015, 46(4):268-272. (in Chinese)
[24] Paldino G, Faienza MF, Cappa M, et al. Analysis of a series of Italian APECED patients with autoimmune hepatitis and gastro-enteropathies[J]. Front Immunol, 2023, 14:1172369.
[25] Orlova EM, Sozaeva LS, Kareva MA, et al. Expanding the phenotypic and genotypic landscape of autoimmune polyendocrine syndrome type 1[J]. J Clin Endocrinol Metab, 2017, 102(9):3546-3556.
[26] Mesbah Z, Tiwari N, Sacco K. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy-associated hepatitis[J]. ACG Case Rep J, 2023, 10(12):e01235.
[27] Lévy R, Escudier A, Bastard P, et al. Ruxolitinib rescues multiorgan clinical autoimmunity in patients with APS-1[J]. J Clin Immunol 2023, 44(1):5.
[28] Aytekin ES, Cagdas D. APECED and the place of AIRE in the puzzle of the immune network associated with autoimmunity[J]. Scand J Immunol, 2023, 98(2):e13299.
[29] Husebye ES, Ingelfinger JR, Anderson MS, et al. Autoimmune polyendocrine syndromes[J]. N Engl J Med, 2018, 378(12):1132-1141.
[30] Jacobson JD, Broussard JR, Marsh C, et al. Attenuation of autoimmune phenomena in a patient with autoimmune polyglandular syndrome type 1[J]. Case Rep Endocrinol, 2021, 2021:1-5.
[31] Borchers J, Pukkala E, Mäkitie O, et al. Patients with APECED have increased early mortality due to endocrine causes, malignancies and infections[J].J Clin Endocrinol Metab, 2020, 105(6):e2207-e2213.

A case of autoimmune polyendocrine syndrome type 1

自身免疫性多发内分泌腺病综合征1型1例

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

[1]	SONG Yi. Impact of social and natural environmental exposure on healthy development of adolescents and preventive strategies [J]. Chinese Journal of Child Health Care, 2025, 33(12): 1281-1286.
[2]	WANG Yirou, WANG Xiumin. Identification of phenotypes in short stature with genetic variation [J]. Chinese Journal of Child Health Care, 2025, 33(12): 1287-1290.
[3]	ZHANG Zongcui, MA Wei, ZHANG Hongxiao, WANG Ling, LIU Jinying, MA Wenyuan, SHI Rui, ZHANG Yu. Correlation of SPOCK and TMEM38B gene polymorphisms with age at menarche in girls from the Sunan region [J]. Chinese Journal of Child Health Care, 2025, 33(12): 1291-1297.
[4]	CHEN Rong, CAI Yingying, LI Qinyu, CHEN Liangliang, LIU Xiumei. Influencing factors and combined effects in children with tic disorder and comorbid attention-deficit/hyperactivity disorder [J]. Chinese Journal of Child Health Care, 2025, 33(12): 1298-1302.
[5]	HUA Jing, CHI Xia, SONG Jun, RUI Hongxin, ZHOU Jianyong, LIN Feng. Item response theory model for the home toy inventory assessment in infants [J]. Chinese Journal of Child Health Care, 2025, 33(12): 1303-1309.
[6]	WANG Yating, HUANG Meihuan, CUI Ruiqing, ZHOU Chunming, ZHONG Jiamin, YUN Guojun. Assessment oflongitudinal changes in motor function in children with Duchenne muscular dystrophy using motor function measurement and timed function tests [J]. Chinese Journal of Child Health Care, 2025, 33(12): 1310-1315.
[7]	LAI Qiankun, LI Yinzhi, HUANG Qi, GUO Jingmin, YAO Qingshan. Genetically predicted causal effects between cytomegalovirus infection and neurodevelopmental disorders [J]. Chinese Journal of Child Health Care, 2025, 33(12): 1316-1322.
[8]	LU Lin, SONG Yang, YIN Keli, REN Geng, XI Lili. Relationship between parental empathy and responsive caregiving for infants and young children [J]. Chinese Journal of Child Health Care, 2025, 33(12): 1323-1327.
[9]	GE Jingjing, WANG Weikai. Association between birth weight and neuropsychological development among children aged 0 - 6 months [J]. Chinese Journal of Child Health Care, 2025, 33(12): 1328-1332.
[10]	HOU Yaoqi, LEI Zonghan, WANG Yan, LU Wanjing, LIU Hong, SONG Xiangqin. Research progress on the exercise intervention for children and adolescents with developmental coordination disorder [J]. Chinese Journal of Child Health Care, 2025, 33(12): 1333-1337.
[11]	HUO Yunfeng, WU Juanjuan, WANG Hua. Progress on the impact of gestational diabetes mellitus on offspring neuropsychological development and its mechanisms [J]. Chinese Journal of Child Health Care, 2025, 33(12): 1338-1342.
[12]	ZHONG Jiamin, ZHOU Chunming, HUANG Meihuan, CHEN Yijing, WANG Yating, CAO Jianguo. Advances in the assessment and intervention of selective motor control in upper limb among children with spastic cerebral palsy [J]. Chinese Journal of Child Health Care, 2025, 33(12): 1343-1347.
[13]	ZHI Jincao, XU He, CHANG Qing, WU Shanhong, QIN Huan, WANG Yan. Research progress on the mechanism of perinatal depression′s impact on offspring neurofunctional development [J]. Chinese Journal of Child Health Care, 2025, 33(12): 1348-1352.
[14]	GUO Hongjie, CHANG Wanpeng, LIU Shuai, HUANG Yan. Research progress on the effects of different whole-body vibration parameters on motor function of children with cerebral palsy [J]. Chinese Journal of Child Health Care, 2025, 33(12): 1353-1357.
[15]	FANG Enhui, GUAN Hui, TIAN Jinxin, ZHANG Hao, MA Lihong. Meta-analysis on the efficacy of family interventions for children with cerebral palsy [J]. Chinese Journal of Child Health Care, 2025, 33(12): 1358-1366.